Gayane Badalain-Very

Summary

Affiliation: Dana Farber Cancer Institute
Location: Boston, USA
URL: http://www.mendeley.com/profiles/gayane-badalian-very/
Summary:
Feb 2012 Claudia adam Barr award
Dec 2011 Histiocytosis Association
Dec 2010 Histiocytosis Association
Dec 2008 Histiocytosis Association

Publications

  1. ncbi HER-2/neu genotype of breast cancer may change in bone metastasis
    Tamás Lôrincz
    Department of Orthopedics, Semmelweis University, Budapest, Hungary
    Pathol Oncol Res 12:149-52. 2006
  2. ncbi EGFR and VEGFR2 protein expressions in bone metastases of clear cell renal cancer
    Gayane Badalian
    Department of Orthopaedics, Semmelweis University, Budapest
    Anticancer Res 27:889-94. 2007
  3. ncbi Phenotype of bone metastases of non-small cell lung cancer: epidermal growth factor receptor expression and K-RAS mutational status
    Gayane Badalian
    Department of Orthopedics, Semmelweis University, Budapest, Hungary
    Pathol Oncol Res 13:99-104. 2007
  4. pmc Recurrent BRAF mutations in Langerhans cell histiocytosis
    Gayane Badalian-Very
    Department of Medical Oncology, Dana Farber Cancer Institute, 44 Binney St, Boston, MA 02115, USA
    Blood 116:1919-23. 2010
  5. doi Recent advances in the understanding of Langerhans cell histiocytosis
    Gayane Badalian-Very
    Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA 02215, USA
    Br J Haematol 156:163-72. 2012
  6. doi Pathogenesis of Langerhans cell histiocytosis
    Gayane Badalian-Very
    Department of Medical Oncology, Dana Farber Cancer Institute, and Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02215, USA
    Annu Rev Pathol 8:1-20. 2013

Collaborators

Detail Information

Publications7

  1. ncbi HER-2/neu genotype of breast cancer may change in bone metastasis
    Tamás Lôrincz
    Department of Orthopedics, Semmelweis University, Budapest, Hungary
    Pathol Oncol Res 12:149-52. 2006
    ....
  2. ncbi EGFR and VEGFR2 protein expressions in bone metastases of clear cell renal cancer
    Gayane Badalian
    Department of Orthopaedics, Semmelweis University, Budapest
    Anticancer Res 27:889-94. 2007
    ..The skeletal system is one of the most common metastatic sites of RCC. Unfortunately, there are no data for EGFR and VEGFR2 protein expression in such lesions...
  3. ncbi Phenotype of bone metastases of non-small cell lung cancer: epidermal growth factor receptor expression and K-RAS mutational status
    Gayane Badalian
    Department of Orthopedics, Semmelweis University, Budapest, Hungary
    Pathol Oncol Res 13:99-104. 2007
    ..It is noteworthy that in NSCLC cases with wt- or mutant KRAS, downregulation of EGFR expression was a rare event although upregulation in bone metastases was observed more frequently in wt K-RAS cases...
  4. pmc Recurrent BRAF mutations in Langerhans cell histiocytosis
    Gayane Badalian-Very
    Department of Medical Oncology, Dana Farber Cancer Institute, 44 Binney St, Boston, MA 02115, USA
    Blood 116:1919-23. 2010
    ..High prevalence, recurrent BRAF mutations in LCH indicate that it is a neoplastic disease that may respond to RAF pathway inhibitors...
  5. doi Recent advances in the understanding of Langerhans cell histiocytosis
    Gayane Badalian-Very
    Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA 02215, USA
    Br J Haematol 156:163-72. 2012
    ..Together, these observations have produced a new picture of LCH as a myeloid neoplasm. These advances are likely to have profound implications for the use of targeted therapeutics in LCH...
  6. doi Pathogenesis of Langerhans cell histiocytosis
    Gayane Badalian-Very
    Department of Medical Oncology, Dana Farber Cancer Institute, and Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02215, USA
    Annu Rev Pathol 8:1-20. 2013
    ..These new observations point the way to rationally targeted therapies...